Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/71/fb/42/71fb42b7-8420-48db-f2b7-9023897e2138/mza_382675112965231730.jpg/600x600bb.jpg
EASL Podcasts
European Association for the Study of the Liver
134 episodes
5 days ago
After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode, experts review emerging data and explore whether we’re approaching a new era of effective treatment. How should clinicians assess these therapies, and could they shift the current management of PSC? Moderator: Debbie Shawcross Speakers: Cynthia Levy, Stephen Rossi, Michael Trauner All EASL Studio Podcasts are available on EASL Campus. Click here to see all EAS...
Show more...
Medicine
Health & Fitness
RSS
All content for EASL Podcasts is the property of European Association for the Study of the Liver and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode, experts review emerging data and explore whether we’re approaching a new era of effective treatment. How should clinicians assess these therapies, and could they shift the current management of PSC? Moderator: Debbie Shawcross Speakers: Cynthia Levy, Stephen Rossi, Michael Trauner All EASL Studio Podcasts are available on EASL Campus. Click here to see all EAS...
Show more...
Medicine
Health & Fitness
Episodes (20/134)
EASL Podcasts
EASL Studio Podcast: Are we finally entering an era of effective treatment for PSC?
After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode, experts review emerging data and explore whether we’re approaching a new era of effective treatment. How should clinicians assess these therapies, and could they shift the current management of PSC? Moderator: Debbie Shawcross Speakers: Cynthia Levy, Stephen Rossi, Michael Trauner All EASL Studio Podcasts are available on EASL Campus. Click here to see all EAS...
Show more...
6 days ago
42 minutes

EASL Podcasts
EASL Studio Podcast: Does it really matter whether we call it ACLF or acute decompensation?
This episode questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on the specifics of organ failure and reversibility is more useful. Experts debate the real-world utility of prognostic scores, the clarity (or confusion) created by multiple definitions, and whether the ACLF concept drives urgency, facilitates transplant access, or improves outcomes. A thought-provoking look at where terminology meets bedside care. Moderator: T...
Show more...
1 month ago
31 minutes

EASL Podcasts
EASL Studio Podcast: The Clinical Blind Spot: Are We Neglecting Alcohol?
This EASL Studio explores the discrepancy between the huge burden of patients hospitalised with, and dying from, alcohol-related liver disease (ALD) or MetALD, versus the same disease’s near non-existence from population data. The panel will discuss whether current classification systems (heavily favoring metabolic causes) misrepresent the true burden of ALD and MetALD, and what clinicians can do to better map the role of alcohol in liver patients. Moderator: Maja Thiele Speakers: Brian Lee, ...
Show more...
1 month ago
34 minutes

EASL Podcasts
EASL Studio Podcast: Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025?
What do we call it when someone with high-risk practices becomes viraemic again after treatment? In this episode, experts discuss the challenges of managing Hepatitis C in people who inject drugs (PWID) and other high-risk groups. Topics include SVR confirmation rates, DAA prescribing practices, acute vs. chronic infection, and real-world reinfection data. Are traditional labels still meaningful or do we need new frameworks for 2025? Moderator: Ahmed Elsharkawy Speakers: Ashley Brown, Tatyana...
Show more...
1 month ago
35 minutes

EASL Podcasts
EASL Studio Podcast: What Matters Most? The questions every hepatologist should ask their patients
In hepatology, effective care goes beyond diagnostics and treatment. This episode explores the crucial questions hepatologists should ask to truly understand their patients’ needs, values, and priorities. By focusing on communication and patient-centred care, our experts highlight how listening carefully can improve adherence, enhance quality of life, and ultimately lead to better outcomes. Moderator: Pierre-Emmanuel Rautou Speakers: Agnès Dumas, Maria Hjorth, José Willemse, Zobair Younossi A...
Show more...
1 month ago
33 minutes

EASL Podcasts
EASL DeepDive: Diagnosis, non-invasive screening and risk stratification of MASLD cases
This first session in a two-part EASL DeepDive series on the 2024 EASL-EASD-EASO MASLD Clinical Practice Guidelines will provide a detailed examination of the recommendations concerning diagnosis, non-invasive assessment, and risk stratification, with a view to supporting evidence-based clinical practice. Learning objectives Have a good understanding of the concept/definition of MASLD within the framework of the new SLD nomenclature, including its contribution to disease progression in other ...
Show more...
4 months ago
1 hour 6 minutes

EASL Podcasts
EASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New?
This episode addresses key challenges in vascular complications of liver disease, including the management of portal vein thrombosis (PVT) in patients with and without cirrhosis. Experts will explore controversies surrounding long-term anticoagulation therapy and discuss insights from the CIRROXABAN paper. Additionally, the episode will shed light on the management of splanchnic artery aneurysms, offering valuable guidance for clinical practice. Moderator: Pierre-Emmanuel Rautou; Facult...
Show more...
4 months ago
32 minutes

EASL Podcasts
EASL DeepDive: MASLD Cirrhosis: Addressing unmet needs and defining valuable endpoints
In this new edition of the EASL DeepDive, expert faculty guide participants through a focused and forward-looking discussion on key aspects of advanced MASLD, setting the stage for a deeper understanding of evolving clinical challenges and opportunities. This EASL DeepDive webinar is supported by Boehringer Ingelheim. Boehringer Ingelheim has had no input into the content of this EASL DeepDive. Learning objectives Understand the Pathophysiology: Describe the key pathophysiological mechanisms...
Show more...
5 months ago
1 hour 10 minutes

EASL Podcasts
EASL Studio Podcast: Steatotic Liver Disease Unpacked: Targeting Dynamic Risks
This EASL Studio episode explores state-of-the-art practices in diagnosing steatotic liver disease and stratifying patients effectively for targeted treatment in 2025. Focusing on integrating cardiometabolic risk profiling and dynamic alcohol consumption assessment, the discussion will discuss contemporary methods, frequency, and practical implementation in clinical settings to enhance precision medicine approaches. Moderator: Aleksander Krag Faculty: Meena Bansal, Mattias Ekstedt, Arun...
Show more...
5 months ago
35 minutes

EASL Podcasts
EASL Studio Podcast: Artificial Intelligence: Is This the Beginning of the End of the Medical Profession as We Know It?
Listen to this EASL Studio episode to explore how artificial intelligence (AI) is transforming healthcare. Discuss its potential to revolutionise medical practice, its limitations, and whether it poses a threat or an opportunity for the future of the medical profession. Moderator: Ahmed Elsharkawy Faculty: Jakob Kather, Sabela Lens, Ashley Spann Related episodes: EASL Studio at EASL Congress 2024 – Exploring new frontiers: The AI liver taskforce initiativeS4E5 – AI for dummiesS2E...
Show more...
5 months ago
36 minutes

EASL Podcasts
EASL Studio Podcast: Rethinking Hepatitis B: Discussions with Patients – Adapting to Expanding Treatment Guidelines
With the release of the new HBV guidelines, treatment eligibility broadens. This EASL Studio explores how to communicate these changes, support shared decision-making, ensure adherence, and engage patients in ongoing care and clinical trials. Moderator: Ahmed Elsharkawy Faculty: Markus Cornberg, Sital Shah, Thomas Tu, Su Wang This EASL Studio is supported by Aligos Therapeutics, GSK and Gilead Sciences Europe Ltd . EASL has received no input from Aligos Therapeutics, GSK or Gilead Scien...
Show more...
5 months ago
36 minutes

EASL Podcasts
EASL Studio Podcast: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical Practice
Listen to this EASL Studio episode for insights on the new MASLD guidelines and their practical application. Hear from experts on navigating the nomenclature change, implementing guidelines in clinical workflows, and fostering behavioral change to improve patient outcomes across the care team. Moderator: Sven Francque Faculty: Marta Cervera, Elena George, Shelley Keating This programme is part of the EASL Guidelines Implementation Programme on MASLD supported by Boehringer Ingelheim and...
Show more...
5 months ago
27 minutes

EASL Podcasts
EASL Studio Podcast: Beyond the myths: Alcohol harm and policy action
This EASL Studio episode cuts through the noise to explore alcohol’s true impact on health and society, spotlighting patient stories, public misconceptions, and bold policy solutions from across Europe. Moderator: David Barret (Internal Communications and Multimedia Manager, WHO Regional Office for Europe) Faculty: Carina Ferreira-Borges (Regional Advisor for Alcohol, Illicit drugs and Prison health, WHO Regional Office for Europe), Aleksander Krag (EASL Secretary General), Hazel Martin (BBC ...
Show more...
5 months ago
47 minutes

EASL Podcasts
EASL Studio Podcast: Landmark studies at EASL Congress 2025
Listen to this episode for a curated overview of landmark studies and breakthrough data presented at EASL Congress 2025, with expert insights on their clinical relevance and impact on the future of hepatology. Moderator: Thomas Berg Faculty: Hannes Hagström, Verena Keitel, Raj Mookerjee All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Video Podcasts on Apple Podcasts.
Show more...
5 months ago
36 minutes

EASL Podcasts
EASL Studio Podcast: Screening strategies for liver fibrosis
Most liver diseases are diagnosed when it’s already too late. This episode explores the pros and cons of early screening, the gaps in current strategies, and how projects like LIVERAiM are aiming to change the game. Moderator: Ahmed Elsharkawy Faculty: Pere Ginès, Ian Rowe, Maja Thiele All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Video Podcasts on Apple Podcasts.
Show more...
5 months ago
31 minutes

EASL Podcasts
EASL/CIRSE Studio Podcast: Interventional radiology in hepatology: Building bridges to optimise care
What happens when hepatologists and interventional radiologists join forces? This episode discusses the power of collaboration – shared guidelines, joint training, and multidisciplinary care – to improve outcomes in complex liver disease. Moderator: Sven Francque Faculty: Irene Bargellini, Virginia Hernández-Gea, Max Seidensticker All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Video Podcasts on Apple Podcasts.
Show more...
5 months ago
30 minutes

EASL Podcasts
EASL DeepDive: Key for TIPS Success: Identifying Suitable Candidates and Risk Control
In this fifth edition of the EASL DeepDive, join Christophe Bureau, Virginia Hernandez-Gea, Marika Rudler, and Manhal Izzy to gain expert insight into the selection, management, and outcomes of patients undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures. This EASL DeepDive webinar is supported by W. L. Gore & Associates. W. L. Gore & Associates has had no input into the content of this EASL DeepDive. Learning objectives Understand the criteria for selecting app...
Show more...
6 months ago
1 hour 32 minutes

EASL Podcasts
EASL Studio Podcast: Endoscopic Management of Variceal Bleeding: Outdated or Evolving Beyond Tradition?
This EASL Studio episode discusses cutting-edge approaches for managing bleeding varices. Explore the evolution of endoscopic therapies, the role of interventional radiology, and decision-making for high-risk gastric varices. Gain insights into EUS-guided portal pressure assessment and its impact on tailoring treatment strategies. Moderator: Debbie Shawcross Faculty: Wim Laleman, David Patch Related episode S6E14: Endohepatology: The endoscopic liver gold rushAll EASL Studio Podcasts are avai...
Show more...
7 months ago
45 minutes

EASL Podcasts
EASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin Deficiency
In this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency. Learning objectives: Learn more about the role of heterozygosity of alpha-1 as a risk factor for chronic liver disease, especially in the context of other causes such as MASLD or alcoholGet a better understanding of the extrahepatic manifestations and the need for a multi-disciplinary approachLearn more a...
Show more...
7 months ago
1 hour 7 minutes

EASL Podcasts
EASL DeepDive: Understanding and managing PBC symptoms
In this EASL DeepDive held on 03 July 2024, Palak Trivedi, Emma Culver, Andreas Kremer and Jessica Dyson explain the risk assessment in people with PBC as well as the mechanistic and treatment of fatigue and pruritus. Learning objectives Discover the latest mechanistic insights relating to the occurrence of PBC symptomsLearn more about the holistic management of PBC symptoms, with a particular emphasis on fatigue and pruritusLearn more about the current treatment options, their efficacy and l...
Show more...
7 months ago
1 hour 15 minutes

EASL Podcasts
After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode, experts review emerging data and explore whether we’re approaching a new era of effective treatment. How should clinicians assess these therapies, and could they shift the current management of PSC? Moderator: Debbie Shawcross Speakers: Cynthia Levy, Stephen Rossi, Michael Trauner All EASL Studio Podcasts are available on EASL Campus. Click here to see all EAS...